1. Home
  2. POAI vs IBG Comparison

POAI vs IBG Comparison

Compare POAI & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • IBG
  • Stock Information
  • Founded
  • POAI 2002
  • IBG 2018
  • Country
  • POAI United States
  • IBG Australia
  • Employees
  • POAI N/A
  • IBG N/A
  • Industry
  • POAI Industrial Specialties
  • IBG Beverages (Production/Distribution)
  • Sector
  • POAI Health Care
  • IBG Consumer Staples
  • Exchange
  • POAI Nasdaq
  • IBG Nasdaq
  • Market Cap
  • POAI 7.8M
  • IBG 7.8M
  • IPO Year
  • POAI N/A
  • IBG 2024
  • Fundamental
  • Price
  • POAI $14.77
  • IBG $3.33
  • Analyst Decision
  • POAI Hold
  • IBG Strong Buy
  • Analyst Count
  • POAI 1
  • IBG 1
  • Target Price
  • POAI N/A
  • IBG N/A
  • AVG Volume (30 Days)
  • POAI 230.9K
  • IBG 6.0M
  • Earning Date
  • POAI 11-11-2025
  • IBG 11-15-2025
  • Dividend Yield
  • POAI N/A
  • IBG N/A
  • EPS Growth
  • POAI N/A
  • IBG N/A
  • EPS
  • POAI N/A
  • IBG N/A
  • Revenue
  • POAI $1,664,696.00
  • IBG $2,931,243.00
  • Revenue This Year
  • POAI $486.27
  • IBG N/A
  • Revenue Next Year
  • POAI $65.50
  • IBG N/A
  • P/E Ratio
  • POAI N/A
  • IBG N/A
  • Revenue Growth
  • POAI 71.65
  • IBG N/A
  • 52 Week Low
  • POAI $8.25
  • IBG $1.48
  • 52 Week High
  • POAI $45.90
  • IBG $11.50
  • Technical
  • Relative Strength Index (RSI)
  • POAI 78.34
  • IBG 62.66
  • Support Level
  • POAI $12.15
  • IBG $2.16
  • Resistance Level
  • POAI $15.15
  • IBG $5.38
  • Average True Range (ATR)
  • POAI 1.98
  • IBG 0.72
  • MACD
  • POAI 1.19
  • IBG 0.10
  • Stochastic Oscillator
  • POAI 45.66
  • IBG 48.70

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About IBG Innovation Beverage Group Limited Ordinary Shares

Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.

Share on Social Networks: